Global Glucagon Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Glucagon market size was valued at US$ 643 million in 2024 and is forecast to a readjusted size of USD 960 million by 2031 with a CAGR of 6.0% during review period.
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
This report is a detailed and comprehensive analysis for global Glucagon market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Glucagon market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Glucagon market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Glucagon market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Glucagon market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Glucagon
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Glucagon market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals, Xeris Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Glucagon market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucagon product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Glucagon, with price, sales quantity, revenue, and global market share of Glucagon from 2020 to 2025.
Chapter 3, the Glucagon competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Glucagon market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Glucagon.
Chapter 14 and 15, to describe Glucagon sales channel, distributors, customers, research findings and conclusion.
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
This report is a detailed and comprehensive analysis for global Glucagon market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Glucagon market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Glucagon market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Glucagon market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Glucagon market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Glucagon
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Glucagon market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals, Xeris Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Glucagon market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Inject Glucagon
- Nasal Glucagon
- Emergency Kits
- General Use
- Diagnostic & Motility
- Cardiogenic Shock
- Others
- Novo Nordisk
- Eli Lilly
- Fresenius Kabi
- Torrent Labs
- Taj Pharmaceuticals
- Xeris Pharmaceuticals
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucagon product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Glucagon, with price, sales quantity, revenue, and global market share of Glucagon from 2020 to 2025.
Chapter 3, the Glucagon competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Glucagon market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Glucagon.
Chapter 14 and 15, to describe Glucagon sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Glucagon Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Inject Glucagon
1.3.3 Nasal Glucagon
1.4 Market Analysis by Application
1.4.1 Overview: Global Glucagon Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Emergency Kits
1.4.3 General Use
1.4.4 Diagnostic & Motility
1.4.5 Cardiogenic Shock
1.4.6 Others
1.5 Global Glucagon Market Size & Forecast
1.5.1 Global Glucagon Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Glucagon Sales Quantity (2020-2031)
1.5.3 Global Glucagon Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Glucagon Product and Services
2.1.4 Novo Nordisk Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Novo Nordisk Recent Developments/Updates
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Glucagon Product and Services
2.2.4 Eli Lilly Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Eli Lilly Recent Developments/Updates
2.3 Fresenius Kabi
2.3.1 Fresenius Kabi Details
2.3.2 Fresenius Kabi Major Business
2.3.3 Fresenius Kabi Glucagon Product and Services
2.3.4 Fresenius Kabi Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Fresenius Kabi Recent Developments/Updates
2.4 Torrent Labs
2.4.1 Torrent Labs Details
2.4.2 Torrent Labs Major Business
2.4.3 Torrent Labs Glucagon Product and Services
2.4.4 Torrent Labs Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Torrent Labs Recent Developments/Updates
2.5 Taj Pharmaceuticals
2.5.1 Taj Pharmaceuticals Details
2.5.2 Taj Pharmaceuticals Major Business
2.5.3 Taj Pharmaceuticals Glucagon Product and Services
2.5.4 Taj Pharmaceuticals Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Taj Pharmaceuticals Recent Developments/Updates
2.6 Xeris Pharmaceuticals
2.6.1 Xeris Pharmaceuticals Details
2.6.2 Xeris Pharmaceuticals Major Business
2.6.3 Xeris Pharmaceuticals Glucagon Product and Services
2.6.4 Xeris Pharmaceuticals Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Xeris Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: GLUCAGON BY MANUFACTURER
3.1 Global Glucagon Sales Quantity by Manufacturer (2020-2025)
3.2 Global Glucagon Revenue by Manufacturer (2020-2025)
3.3 Global Glucagon Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Glucagon by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Glucagon Manufacturer Market Share in 2024
3.4.3 Top 6 Glucagon Manufacturer Market Share in 2024
3.5 Glucagon Market: Overall Company Footprint Analysis
3.5.1 Glucagon Market: Region Footprint
3.5.2 Glucagon Market: Company Product Type Footprint
3.5.3 Glucagon Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Glucagon Market Size by Region
4.1.1 Global Glucagon Sales Quantity by Region (2020-2031)
4.1.2 Global Glucagon Consumption Value by Region (2020-2031)
4.1.3 Global Glucagon Average Price by Region (2020-2031)
4.2 North America Glucagon Consumption Value (2020-2031)
4.3 Europe Glucagon Consumption Value (2020-2031)
4.4 Asia-Pacific Glucagon Consumption Value (2020-2031)
4.5 South America Glucagon Consumption Value (2020-2031)
4.6 Middle East & Africa Glucagon Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Glucagon Sales Quantity by Type (2020-2031)
5.2 Global Glucagon Consumption Value by Type (2020-2031)
5.3 Global Glucagon Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Glucagon Sales Quantity by Application (2020-2031)
6.2 Global Glucagon Consumption Value by Application (2020-2031)
6.3 Global Glucagon Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Glucagon Sales Quantity by Type (2020-2031)
7.2 North America Glucagon Sales Quantity by Application (2020-2031)
7.3 North America Glucagon Market Size by Country
7.3.1 North America Glucagon Sales Quantity by Country (2020-2031)
7.3.2 North America Glucagon Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Glucagon Sales Quantity by Type (2020-2031)
8.2 Europe Glucagon Sales Quantity by Application (2020-2031)
8.3 Europe Glucagon Market Size by Country
8.3.1 Europe Glucagon Sales Quantity by Country (2020-2031)
8.3.2 Europe Glucagon Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Glucagon Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Glucagon Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Glucagon Market Size by Region
9.3.1 Asia-Pacific Glucagon Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Glucagon Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Glucagon Sales Quantity by Type (2020-2031)
10.2 South America Glucagon Sales Quantity by Application (2020-2031)
10.3 South America Glucagon Market Size by Country
10.3.1 South America Glucagon Sales Quantity by Country (2020-2031)
10.3.2 South America Glucagon Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Glucagon Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Glucagon Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Glucagon Market Size by Country
11.3.1 Middle East & Africa Glucagon Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Glucagon Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Glucagon Market Drivers
12.2 Glucagon Market Restraints
12.3 Glucagon Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Glucagon and Key Manufacturers
13.2 Manufacturing Costs Percentage of Glucagon
13.3 Glucagon Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Glucagon Typical Distributors
14.3 Glucagon Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Glucagon Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Inject Glucagon
1.3.3 Nasal Glucagon
1.4 Market Analysis by Application
1.4.1 Overview: Global Glucagon Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Emergency Kits
1.4.3 General Use
1.4.4 Diagnostic & Motility
1.4.5 Cardiogenic Shock
1.4.6 Others
1.5 Global Glucagon Market Size & Forecast
1.5.1 Global Glucagon Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Glucagon Sales Quantity (2020-2031)
1.5.3 Global Glucagon Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Glucagon Product and Services
2.1.4 Novo Nordisk Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Novo Nordisk Recent Developments/Updates
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Glucagon Product and Services
2.2.4 Eli Lilly Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Eli Lilly Recent Developments/Updates
2.3 Fresenius Kabi
2.3.1 Fresenius Kabi Details
2.3.2 Fresenius Kabi Major Business
2.3.3 Fresenius Kabi Glucagon Product and Services
2.3.4 Fresenius Kabi Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Fresenius Kabi Recent Developments/Updates
2.4 Torrent Labs
2.4.1 Torrent Labs Details
2.4.2 Torrent Labs Major Business
2.4.3 Torrent Labs Glucagon Product and Services
2.4.4 Torrent Labs Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Torrent Labs Recent Developments/Updates
2.5 Taj Pharmaceuticals
2.5.1 Taj Pharmaceuticals Details
2.5.2 Taj Pharmaceuticals Major Business
2.5.3 Taj Pharmaceuticals Glucagon Product and Services
2.5.4 Taj Pharmaceuticals Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Taj Pharmaceuticals Recent Developments/Updates
2.6 Xeris Pharmaceuticals
2.6.1 Xeris Pharmaceuticals Details
2.6.2 Xeris Pharmaceuticals Major Business
2.6.3 Xeris Pharmaceuticals Glucagon Product and Services
2.6.4 Xeris Pharmaceuticals Glucagon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Xeris Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: GLUCAGON BY MANUFACTURER
3.1 Global Glucagon Sales Quantity by Manufacturer (2020-2025)
3.2 Global Glucagon Revenue by Manufacturer (2020-2025)
3.3 Global Glucagon Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Glucagon by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Glucagon Manufacturer Market Share in 2024
3.4.3 Top 6 Glucagon Manufacturer Market Share in 2024
3.5 Glucagon Market: Overall Company Footprint Analysis
3.5.1 Glucagon Market: Region Footprint
3.5.2 Glucagon Market: Company Product Type Footprint
3.5.3 Glucagon Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Glucagon Market Size by Region
4.1.1 Global Glucagon Sales Quantity by Region (2020-2031)
4.1.2 Global Glucagon Consumption Value by Region (2020-2031)
4.1.3 Global Glucagon Average Price by Region (2020-2031)
4.2 North America Glucagon Consumption Value (2020-2031)
4.3 Europe Glucagon Consumption Value (2020-2031)
4.4 Asia-Pacific Glucagon Consumption Value (2020-2031)
4.5 South America Glucagon Consumption Value (2020-2031)
4.6 Middle East & Africa Glucagon Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Glucagon Sales Quantity by Type (2020-2031)
5.2 Global Glucagon Consumption Value by Type (2020-2031)
5.3 Global Glucagon Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Glucagon Sales Quantity by Application (2020-2031)
6.2 Global Glucagon Consumption Value by Application (2020-2031)
6.3 Global Glucagon Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Glucagon Sales Quantity by Type (2020-2031)
7.2 North America Glucagon Sales Quantity by Application (2020-2031)
7.3 North America Glucagon Market Size by Country
7.3.1 North America Glucagon Sales Quantity by Country (2020-2031)
7.3.2 North America Glucagon Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Glucagon Sales Quantity by Type (2020-2031)
8.2 Europe Glucagon Sales Quantity by Application (2020-2031)
8.3 Europe Glucagon Market Size by Country
8.3.1 Europe Glucagon Sales Quantity by Country (2020-2031)
8.3.2 Europe Glucagon Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Glucagon Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Glucagon Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Glucagon Market Size by Region
9.3.1 Asia-Pacific Glucagon Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Glucagon Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Glucagon Sales Quantity by Type (2020-2031)
10.2 South America Glucagon Sales Quantity by Application (2020-2031)
10.3 South America Glucagon Market Size by Country
10.3.1 South America Glucagon Sales Quantity by Country (2020-2031)
10.3.2 South America Glucagon Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Glucagon Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Glucagon Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Glucagon Market Size by Country
11.3.1 Middle East & Africa Glucagon Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Glucagon Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Glucagon Market Drivers
12.2 Glucagon Market Restraints
12.3 Glucagon Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Glucagon and Key Manufacturers
13.2 Manufacturing Costs Percentage of Glucagon
13.3 Glucagon Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Glucagon Typical Distributors
14.3 Glucagon Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Glucagon Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Glucagon Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk Glucagon Product and Services
Table 6. Novo Nordisk Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Novo Nordisk Recent Developments/Updates
Table 8. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 9. Eli Lilly Major Business
Table 10. Eli Lilly Glucagon Product and Services
Table 11. Eli Lilly Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Eli Lilly Recent Developments/Updates
Table 13. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 14. Fresenius Kabi Major Business
Table 15. Fresenius Kabi Glucagon Product and Services
Table 16. Fresenius Kabi Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Fresenius Kabi Recent Developments/Updates
Table 18. Torrent Labs Basic Information, Manufacturing Base and Competitors
Table 19. Torrent Labs Major Business
Table 20. Torrent Labs Glucagon Product and Services
Table 21. Torrent Labs Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Torrent Labs Recent Developments/Updates
Table 23. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Taj Pharmaceuticals Major Business
Table 25. Taj Pharmaceuticals Glucagon Product and Services
Table 26. Taj Pharmaceuticals Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Taj Pharmaceuticals Recent Developments/Updates
Table 28. Xeris Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Xeris Pharmaceuticals Major Business
Table 30. Xeris Pharmaceuticals Glucagon Product and Services
Table 31. Xeris Pharmaceuticals Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Xeris Pharmaceuticals Recent Developments/Updates
Table 33. Global Glucagon Sales Quantity by Manufacturer (2020-2025) & (K MT)
Table 34. Global Glucagon Revenue by Manufacturer (2020-2025) & (USD Million)
Table 35. Global Glucagon Average Price by Manufacturer (2020-2025) & (USD/MT)
Table 36. Market Position of Manufacturers in Glucagon, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 37. Head Office and Glucagon Production Site of Key Manufacturer
Table 38. Glucagon Market: Company Product Type Footprint
Table 39. Glucagon Market: Company Product Application Footprint
Table 40. Glucagon New Market Entrants and Barriers to Market Entry
Table 41. Glucagon Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Glucagon Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 43. Global Glucagon Sales Quantity by Region (2020-2025) & (K MT)
Table 44. Global Glucagon Sales Quantity by Region (2026-2031) & (K MT)
Table 45. Global Glucagon Consumption Value by Region (2020-2025) & (USD Million)
Table 46. Global Glucagon Consumption Value by Region (2026-2031) & (USD Million)
Table 47. Global Glucagon Average Price by Region (2020-2025) & (USD/MT)
Table 48. Global Glucagon Average Price by Region (2026-2031) & (USD/MT)
Table 49. Global Glucagon Sales Quantity by Type (2020-2025) & (K MT)
Table 50. Global Glucagon Sales Quantity by Type (2026-2031) & (K MT)
Table 51. Global Glucagon Consumption Value by Type (2020-2025) & (USD Million)
Table 52. Global Glucagon Consumption Value by Type (2026-2031) & (USD Million)
Table 53. Global Glucagon Average Price by Type (2020-2025) & (USD/MT)
Table 54. Global Glucagon Average Price by Type (2026-2031) & (USD/MT)
Table 55. Global Glucagon Sales Quantity by Application (2020-2025) & (K MT)
Table 56. Global Glucagon Sales Quantity by Application (2026-2031) & (K MT)
Table 57. Global Glucagon Consumption Value by Application (2020-2025) & (USD Million)
Table 58. Global Glucagon Consumption Value by Application (2026-2031) & (USD Million)
Table 59. Global Glucagon Average Price by Application (2020-2025) & (USD/MT)
Table 60. Global Glucagon Average Price by Application (2026-2031) & (USD/MT)
Table 61. North America Glucagon Sales Quantity by Type (2020-2025) & (K MT)
Table 62. North America Glucagon Sales Quantity by Type (2026-2031) & (K MT)
Table 63. North America Glucagon Sales Quantity by Application (2020-2025) & (K MT)
Table 64. North America Glucagon Sales Quantity by Application (2026-2031) & (K MT)
Table 65. North America Glucagon Sales Quantity by Country (2020-2025) & (K MT)
Table 66. North America Glucagon Sales Quantity by Country (2026-2031) & (K MT)
Table 67. North America Glucagon Consumption Value by Country (2020-2025) & (USD Million)
Table 68. North America Glucagon Consumption Value by Country (2026-2031) & (USD Million)
Table 69. Europe Glucagon Sales Quantity by Type (2020-2025) & (K MT)
Table 70. Europe Glucagon Sales Quantity by Type (2026-2031) & (K MT)
Table 71. Europe Glucagon Sales Quantity by Application (2020-2025) & (K MT)
Table 72. Europe Glucagon Sales Quantity by Application (2026-2031) & (K MT)
Table 73. Europe Glucagon Sales Quantity by Country (2020-2025) & (K MT)
Table 74. Europe Glucagon Sales Quantity by Country (2026-2031) & (K MT)
Table 75. Europe Glucagon Consumption Value by Country (2020-2025) & (USD Million)
Table 76. Europe Glucagon Consumption Value by Country (2026-2031) & (USD Million)
Table 77. Asia-Pacific Glucagon Sales Quantity by Type (2020-2025) & (K MT)
Table 78. Asia-Pacific Glucagon Sales Quantity by Type (2026-2031) & (K MT)
Table 79. Asia-Pacific Glucagon Sales Quantity by Application (2020-2025) & (K MT)
Table 80. Asia-Pacific Glucagon Sales Quantity by Application (2026-2031) & (K MT)
Table 81. Asia-Pacific Glucagon Sales Quantity by Region (2020-2025) & (K MT)
Table 82. Asia-Pacific Glucagon Sales Quantity by Region (2026-2031) & (K MT)
Table 83. Asia-Pacific Glucagon Consumption Value by Region (2020-2025) & (USD Million)
Table 84. Asia-Pacific Glucagon Consumption Value by Region (2026-2031) & (USD Million)
Table 85. South America Glucagon Sales Quantity by Type (2020-2025) & (K MT)
Table 86. South America Glucagon Sales Quantity by Type (2026-2031) & (K MT)
Table 87. South America Glucagon Sales Quantity by Application (2020-2025) & (K MT)
Table 88. South America Glucagon Sales Quantity by Application (2026-2031) & (K MT)
Table 89. South America Glucagon Sales Quantity by Country (2020-2025) & (K MT)
Table 90. South America Glucagon Sales Quantity by Country (2026-2031) & (K MT)
Table 91. South America Glucagon Consumption Value by Country (2020-2025) & (USD Million)
Table 92. South America Glucagon Consumption Value by Country (2026-2031) & (USD Million)
Table 93. Middle East & Africa Glucagon Sales Quantity by Type (2020-2025) & (K MT)
Table 94. Middle East & Africa Glucagon Sales Quantity by Type (2026-2031) & (K MT)
Table 95. Middle East & Africa Glucagon Sales Quantity by Application (2020-2025) & (K MT)
Table 96. Middle East & Africa Glucagon Sales Quantity by Application (2026-2031) & (K MT)
Table 97. Middle East & Africa Glucagon Sales Quantity by Country (2020-2025) & (K MT)
Table 98. Middle East & Africa Glucagon Sales Quantity by Country (2026-2031) & (K MT)
Table 99. Middle East & Africa Glucagon Consumption Value by Country (2020-2025) & (USD Million)
Table 100. Middle East & Africa Glucagon Consumption Value by Country (2026-2031) & (USD Million)
Table 101. Glucagon Raw Material
Table 102. Key Manufacturers of Glucagon Raw Materials
Table 103. Glucagon Typical Distributors
Table 104. Glucagon Typical Customers
Table 1. Global Glucagon Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Glucagon Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk Glucagon Product and Services
Table 6. Novo Nordisk Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Novo Nordisk Recent Developments/Updates
Table 8. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 9. Eli Lilly Major Business
Table 10. Eli Lilly Glucagon Product and Services
Table 11. Eli Lilly Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Eli Lilly Recent Developments/Updates
Table 13. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 14. Fresenius Kabi Major Business
Table 15. Fresenius Kabi Glucagon Product and Services
Table 16. Fresenius Kabi Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Fresenius Kabi Recent Developments/Updates
Table 18. Torrent Labs Basic Information, Manufacturing Base and Competitors
Table 19. Torrent Labs Major Business
Table 20. Torrent Labs Glucagon Product and Services
Table 21. Torrent Labs Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Torrent Labs Recent Developments/Updates
Table 23. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Taj Pharmaceuticals Major Business
Table 25. Taj Pharmaceuticals Glucagon Product and Services
Table 26. Taj Pharmaceuticals Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Taj Pharmaceuticals Recent Developments/Updates
Table 28. Xeris Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Xeris Pharmaceuticals Major Business
Table 30. Xeris Pharmaceuticals Glucagon Product and Services
Table 31. Xeris Pharmaceuticals Glucagon Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Xeris Pharmaceuticals Recent Developments/Updates
Table 33. Global Glucagon Sales Quantity by Manufacturer (2020-2025) & (K MT)
Table 34. Global Glucagon Revenue by Manufacturer (2020-2025) & (USD Million)
Table 35. Global Glucagon Average Price by Manufacturer (2020-2025) & (USD/MT)
Table 36. Market Position of Manufacturers in Glucagon, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 37. Head Office and Glucagon Production Site of Key Manufacturer
Table 38. Glucagon Market: Company Product Type Footprint
Table 39. Glucagon Market: Company Product Application Footprint
Table 40. Glucagon New Market Entrants and Barriers to Market Entry
Table 41. Glucagon Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Glucagon Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 43. Global Glucagon Sales Quantity by Region (2020-2025) & (K MT)
Table 44. Global Glucagon Sales Quantity by Region (2026-2031) & (K MT)
Table 45. Global Glucagon Consumption Value by Region (2020-2025) & (USD Million)
Table 46. Global Glucagon Consumption Value by Region (2026-2031) & (USD Million)
Table 47. Global Glucagon Average Price by Region (2020-2025) & (USD/MT)
Table 48. Global Glucagon Average Price by Region (2026-2031) & (USD/MT)
Table 49. Global Glucagon Sales Quantity by Type (2020-2025) & (K MT)
Table 50. Global Glucagon Sales Quantity by Type (2026-2031) & (K MT)
Table 51. Global Glucagon Consumption Value by Type (2020-2025) & (USD Million)
Table 52. Global Glucagon Consumption Value by Type (2026-2031) & (USD Million)
Table 53. Global Glucagon Average Price by Type (2020-2025) & (USD/MT)
Table 54. Global Glucagon Average Price by Type (2026-2031) & (USD/MT)
Table 55. Global Glucagon Sales Quantity by Application (2020-2025) & (K MT)
Table 56. Global Glucagon Sales Quantity by Application (2026-2031) & (K MT)
Table 57. Global Glucagon Consumption Value by Application (2020-2025) & (USD Million)
Table 58. Global Glucagon Consumption Value by Application (2026-2031) & (USD Million)
Table 59. Global Glucagon Average Price by Application (2020-2025) & (USD/MT)
Table 60. Global Glucagon Average Price by Application (2026-2031) & (USD/MT)
Table 61. North America Glucagon Sales Quantity by Type (2020-2025) & (K MT)
Table 62. North America Glucagon Sales Quantity by Type (2026-2031) & (K MT)
Table 63. North America Glucagon Sales Quantity by Application (2020-2025) & (K MT)
Table 64. North America Glucagon Sales Quantity by Application (2026-2031) & (K MT)
Table 65. North America Glucagon Sales Quantity by Country (2020-2025) & (K MT)
Table 66. North America Glucagon Sales Quantity by Country (2026-2031) & (K MT)
Table 67. North America Glucagon Consumption Value by Country (2020-2025) & (USD Million)
Table 68. North America Glucagon Consumption Value by Country (2026-2031) & (USD Million)
Table 69. Europe Glucagon Sales Quantity by Type (2020-2025) & (K MT)
Table 70. Europe Glucagon Sales Quantity by Type (2026-2031) & (K MT)
Table 71. Europe Glucagon Sales Quantity by Application (2020-2025) & (K MT)
Table 72. Europe Glucagon Sales Quantity by Application (2026-2031) & (K MT)
Table 73. Europe Glucagon Sales Quantity by Country (2020-2025) & (K MT)
Table 74. Europe Glucagon Sales Quantity by Country (2026-2031) & (K MT)
Table 75. Europe Glucagon Consumption Value by Country (2020-2025) & (USD Million)
Table 76. Europe Glucagon Consumption Value by Country (2026-2031) & (USD Million)
Table 77. Asia-Pacific Glucagon Sales Quantity by Type (2020-2025) & (K MT)
Table 78. Asia-Pacific Glucagon Sales Quantity by Type (2026-2031) & (K MT)
Table 79. Asia-Pacific Glucagon Sales Quantity by Application (2020-2025) & (K MT)
Table 80. Asia-Pacific Glucagon Sales Quantity by Application (2026-2031) & (K MT)
Table 81. Asia-Pacific Glucagon Sales Quantity by Region (2020-2025) & (K MT)
Table 82. Asia-Pacific Glucagon Sales Quantity by Region (2026-2031) & (K MT)
Table 83. Asia-Pacific Glucagon Consumption Value by Region (2020-2025) & (USD Million)
Table 84. Asia-Pacific Glucagon Consumption Value by Region (2026-2031) & (USD Million)
Table 85. South America Glucagon Sales Quantity by Type (2020-2025) & (K MT)
Table 86. South America Glucagon Sales Quantity by Type (2026-2031) & (K MT)
Table 87. South America Glucagon Sales Quantity by Application (2020-2025) & (K MT)
Table 88. South America Glucagon Sales Quantity by Application (2026-2031) & (K MT)
Table 89. South America Glucagon Sales Quantity by Country (2020-2025) & (K MT)
Table 90. South America Glucagon Sales Quantity by Country (2026-2031) & (K MT)
Table 91. South America Glucagon Consumption Value by Country (2020-2025) & (USD Million)
Table 92. South America Glucagon Consumption Value by Country (2026-2031) & (USD Million)
Table 93. Middle East & Africa Glucagon Sales Quantity by Type (2020-2025) & (K MT)
Table 94. Middle East & Africa Glucagon Sales Quantity by Type (2026-2031) & (K MT)
Table 95. Middle East & Africa Glucagon Sales Quantity by Application (2020-2025) & (K MT)
Table 96. Middle East & Africa Glucagon Sales Quantity by Application (2026-2031) & (K MT)
Table 97. Middle East & Africa Glucagon Sales Quantity by Country (2020-2025) & (K MT)
Table 98. Middle East & Africa Glucagon Sales Quantity by Country (2026-2031) & (K MT)
Table 99. Middle East & Africa Glucagon Consumption Value by Country (2020-2025) & (USD Million)
Table 100. Middle East & Africa Glucagon Consumption Value by Country (2026-2031) & (USD Million)
Table 101. Glucagon Raw Material
Table 102. Key Manufacturers of Glucagon Raw Materials
Table 103. Glucagon Typical Distributors
Table 104. Glucagon Typical Customers
LIST OF FIGURES
Figure 1. Glucagon Picture
Figure 2. Global Glucagon Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Glucagon Revenue Market Share by Type in 2024
Figure 4. Inject Glucagon Examples
Figure 5. Nasal Glucagon Examples
Figure 6. Global Glucagon Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Glucagon Revenue Market Share by Application in 2024
Figure 8. Emergency Kits Examples
Figure 9. General Use Examples
Figure 10. Diagnostic & Motility Examples
Figure 11. Cardiogenic Shock Examples
Figure 12. Others Examples
Figure 13. Global Glucagon Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Glucagon Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Glucagon Sales Quantity (2020-2031) & (K MT)
Figure 16. Global Glucagon Price (2020-2031) & (USD/MT)
Figure 17. Global Glucagon Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global Glucagon Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of Glucagon by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 Glucagon Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Glucagon Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Glucagon Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global Glucagon Consumption Value Market Share by Region (2020-2031)
Figure 24. North America Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 27. South America Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 29. Global Glucagon Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global Glucagon Consumption Value Market Share by Type (2020-2031)
Figure 31. Global Glucagon Average Price by Type (2020-2031) & (USD/MT)
Figure 32. Global Glucagon Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global Glucagon Revenue Market Share by Application (2020-2031)
Figure 34. Global Glucagon Average Price by Application (2020-2031) & (USD/MT)
Figure 35. North America Glucagon Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America Glucagon Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America Glucagon Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America Glucagon Consumption Value Market Share by Country (2020-2031)
Figure 39. United States Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe Glucagon Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe Glucagon Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe Glucagon Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe Glucagon Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 47. France Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Glucagon Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific Glucagon Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Glucagon Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Glucagon Consumption Value Market Share by Region (2020-2031)
Figure 55. China Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 58. India Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 61. South America Glucagon Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America Glucagon Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America Glucagon Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America Glucagon Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Glucagon Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Glucagon Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Glucagon Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa Glucagon Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 75. Glucagon Market Drivers
Figure 76. Glucagon Market Restraints
Figure 77. Glucagon Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Glucagon in 2024
Figure 80. Manufacturing Process Analysis of Glucagon
Figure 81. Glucagon Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Glucagon Picture
Figure 2. Global Glucagon Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Glucagon Revenue Market Share by Type in 2024
Figure 4. Inject Glucagon Examples
Figure 5. Nasal Glucagon Examples
Figure 6. Global Glucagon Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Glucagon Revenue Market Share by Application in 2024
Figure 8. Emergency Kits Examples
Figure 9. General Use Examples
Figure 10. Diagnostic & Motility Examples
Figure 11. Cardiogenic Shock Examples
Figure 12. Others Examples
Figure 13. Global Glucagon Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Glucagon Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Glucagon Sales Quantity (2020-2031) & (K MT)
Figure 16. Global Glucagon Price (2020-2031) & (USD/MT)
Figure 17. Global Glucagon Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global Glucagon Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of Glucagon by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 Glucagon Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Glucagon Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Glucagon Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global Glucagon Consumption Value Market Share by Region (2020-2031)
Figure 24. North America Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 27. South America Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 29. Global Glucagon Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global Glucagon Consumption Value Market Share by Type (2020-2031)
Figure 31. Global Glucagon Average Price by Type (2020-2031) & (USD/MT)
Figure 32. Global Glucagon Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global Glucagon Revenue Market Share by Application (2020-2031)
Figure 34. Global Glucagon Average Price by Application (2020-2031) & (USD/MT)
Figure 35. North America Glucagon Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America Glucagon Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America Glucagon Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America Glucagon Consumption Value Market Share by Country (2020-2031)
Figure 39. United States Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe Glucagon Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe Glucagon Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe Glucagon Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe Glucagon Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 47. France Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Glucagon Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific Glucagon Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Glucagon Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Glucagon Consumption Value Market Share by Region (2020-2031)
Figure 55. China Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 58. India Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 61. South America Glucagon Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America Glucagon Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America Glucagon Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America Glucagon Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Glucagon Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Glucagon Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Glucagon Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa Glucagon Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa Glucagon Consumption Value (2020-2031) & (USD Million)
Figure 75. Glucagon Market Drivers
Figure 76. Glucagon Market Restraints
Figure 77. Glucagon Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Glucagon in 2024
Figure 80. Manufacturing Process Analysis of Glucagon
Figure 81. Glucagon Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
